Hyosung Chemical Corporation
298000.KSFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
2,129
Cost of Revenue
2,186
Gross Profit
-58
Gross Margin
-2.7%
Operating Income
-128
Operating Margin
-6.0%
Net Income
-244
Net Margin
-11.5%
EPS (Basic)
$-65.00
EPS (Diluted)
$-65.00
EBITDA
28
EBITDA Margin
1.3%
2023
12/31/2023
Revenue
2,094
Cost of Revenue
2,155
Gross Profit
-62
Gross Margin
-2.9%
Operating Income
-142
Operating Margin
-6.8%
Net Income
-260
Net Margin
-12.4%
EPS (Basic)
$-80.00
EPS (Diluted)
$-80.00
EBITDA
37
EBITDA Margin
1.8%
2022
12/31/2022
Revenue
2,159
Cost of Revenue
2,332
Gross Profit
-173
Gross Margin
-8.0%
Operating Income
-253
Operating Margin
-11.7%
Net Income
-307
Net Margin
-14.2%
EPS (Basic)
$-96.00
EPS (Diluted)
$-96.00
EBITDA
-44
EBITDA Margin
-2.1%
2021
12/31/2021
Revenue
1,840
Cost of Revenue
1,653
Gross Profit
187
Gross Margin
10.2%
Operating Income
111
Operating Margin
6.1%
Net Income
44
Net Margin
2.4%
EPS (Basic)
$14.00
EPS (Diluted)
$14.00
EBITDA
246
EBITDA Margin
13.4%
2020
12/31/2020
Revenue
1,363
Cost of Revenue
1,248
Gross Profit
115
Gross Margin
8.4%
Operating Income
46
Operating Margin
3.4%
Net Income
-9
Net Margin
-0.6%
EPS (Basic)
$-3.00
EPS (Diluted)
$-3.00
EBITDA
168
EBITDA Margin
12.3%